File: Attachment 260113 News Release.pdf

OVATION SCIENCE INC. GRANTS STOCK OPTIONS

Vancouver, BC January 13, 2026 (CSE: OVAT) Ovation Science Inc. ("Ovation" or the "Company") is pleased to announce that the Company has granted 2,200,000 stock options to directors and officers of the Company. The stock options are exercisable at a price of $0.05 per share for a period of two years from the date of grant.

About Ovation Science Inc. Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC and other cannabinoid formulations which are licensed out and also distributed under Ovation's own brands; ARLO CBD Beauty and InVibetrademark MD ("health & wellness" line); all made with its patented Invisicaretrademark skin delivery technology. The Invisicare technology enhances the delivery of ingredients to and through the skin and is protected by patents and proprietary formulations which cannot be duplicated. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation's management and science team have created a unique pipeline of over thirty proprietary medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from royalties on licensees' sales and the sale of Invisicare, along with revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA.

Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Ovation Science Inc. cautions that all forward-looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.'s control.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

FOR INQUIRIES:

info@ovationscience.com Phone: 604.982-5700